These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and cytotoxicity evaluation of novel cyclic/non-cyclic N-aryl enamino amides against human cancer cell lines. Bohlooli S, Nejatkhah N, Sepehri S, Doostkamel D, Razzaghi-Asl N. Res Pharm Sci; 2020 Dec; 15(6):563-570. PubMed ID: 33828599 [Abstract] [Full Text] [Related]
3. Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives. Mohammadi-Ghalehbin B, Shiran JA, Gholizadeh N, Razzaghi-Asl N. Mol Divers; 2023 Aug; 27(4):1531-1545. PubMed ID: 36001225 [Abstract] [Full Text] [Related]
5. Synthesis and cytotoxic effect of a few N-heteroaryl enamino amides and dihydropyrimidinethiones on AGS and MCF-7 human cancer cell lines. Tavangar S, Bohlooli S, Razzaghi-Asl N. Res Pharm Sci; 2020 Apr; 15(2):154-163. PubMed ID: 32582355 [Abstract] [Full Text] [Related]
18. Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis. Rub A, Shaker K, Kashif M, Arish M, Dukhyil AAB, Alshehri BM, Alaidarous MA, Banawas S, Amir K. Protein Pept Lett; 2019 Dec; 26(5):371-376. PubMed ID: 30827222 [Abstract] [Full Text] [Related]
19. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. Nieto-Meneses R, Castillo R, Hernández-Campos A, Maldonado-Rangel A, Matius-Ruiz JB, Trejo-Soto PJ, Nogueda-Torres B, Dea-Ayuela MA, Bolás-Fernández F, Méndez-Cuesta C, Yépez-Mulia L. Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699 [Abstract] [Full Text] [Related]
20. β-Nitrostyrenes as Potential Anti-leishmanial Agents. Shafi S, Afrin F, Islamuddin M, Chouhan G, Ali I, Naaz F, Sharma K, Zaman MS. Front Microbiol; 2016 Jan; 7():1379. PubMed ID: 27635124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]